FebriDX rapid POC test

Know Who Is Viral or Bacterial This Respiratory Season FebriDx® is the first and only rapid point-of-care test to differentiate a viral from bacterial acute respiratory infection (ARI), enabling rapid COVID-19 and flu management.

Know how to manage your patients • Differentiate viral from bacterial ARIs1-2

FebriDx®: • Reduces GP workload • Prevents spread of infection

• Rapidly isolate viral patients3-4

• Faciltates remote testing

• Ensure patients with bacterial infections

• Detects viral ARIs including

are not missed

• Rule out non-clinically significant infections

COVID-19 and flu

• Limits unnecessary antibiotics

RAPID, SIMPLE, ACCURATE, AND COST-EFFECTIVE!

FebriDx CLICK TO ORDER NOW

Simple All-in-one Test. Instrument Free

1

Lance finger

2

Collect blood sample

Optimal Patient Management

3

Deliver blood sample

4

Deliver buffer solution

Prevent Spread of Infection

Patient with acute respiratory infection (e.g., fever, cough, shortness of breath)

SUSPECTED COVID-19 PATIENTS

FebriDx® Rapid Triage Test

10 min.

TRIAGE WITH

VIRAL INFECTION

BACTERIAL INFECTION

Cohort viral patients to prevent spread of infection and prioritise PCR testing

Cohort away from patients with viral infections

FebriDx

®

NONINFECTION

PRESUMPTIVE COVID-19 PATIENTS

NON-COVID-19 PATIENTS

Save Time and Money With a FebriDx® Workflow

FebriDx

®

10 PATIENTS WITH ARI

8 PATIENTS SOLELY MANAGED

BY HEALTHCARE PROFESSIONAL

PATHWAY

10 PATIENTS DISCHARGED

2 PATIENTS SEEN

BY DOCTOR

TRY FEBRIDX ® IN YOUR PRACTICE AND SEE THE BENEFITS. WE WILL TRAIN YOUR STAFF, ASSIST WITH WORKFLOW, AND PROVIDE PATIENT EDUCATION TOOLS. Contact your local Henry Schein Sales Representative at 0800 0304 169 or email info@henryscheinmedical.co.uk 1. Shapiro NI, Self WH, Rosen J, et al. A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever. Ann Med. 2018;18:1-10.

2. Self WH, Rosen J, Sharp SC, et al. Diagnostic accuracy of FebriDx: A rapid test to detect immune responses to viral and bacterial upper respiratory infections. J Clin Med. 2017;6(10):E94.

3. Karim N, Ashraf MZ, Naseem M, et al. Utility of the FebriDx point-of-care test for rapid triage and identification of possible coronavirus disease 2019 (COVID-19). Int J Clin Pract. 2020. In press.

4. Clark TW, Brendish NJ, Poole S, et al. Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19. J Infect. 2020;Epub ahead of print. doi: 10.1016/j.jinf.2020.06.051

FebriDx is not currently available in the United States. ®

PM-068.0 SEPT 2020